皮质发育畸形胎儿的胼胝体比例失调
这项单中心回顾性研究纳入2017年4月至2022年8月孕20-37周的单胎胎儿,评估皮质发育畸形(MCD)胎儿的胼胝体大小,并探讨三种胼胝体长度(CCL)比值识别皮质异常的价值。MCD胎儿的胼胝体长度、高度(膝部和压部)及面积均显著低于正常胎儿,CCL/ICOFD、CCL/FL、CCL/VD比值也显著降低;其中CCL/ICOFD比值预测MCD的AUC最高,为0.856(95%CI:0.774-0.938,P<.001)。作者认为,基于超声测量的CCL/ICOFD比值是产前检测皮质畸形的 promising 工具,但需要外部验证和前瞻性研究。
要点
- MCD胎儿胼胝体长度、膝部和压部高度及面积均显著低于正常胎儿。
- CCL/ICOFD比值预测MCD的AUC为0.856,高于CCL/FL的0.780和CCL/VD的0.677。
- 作者认为CCL/ICOFD比值是产前检测皮质畸形的 promising 工具。
核心结论
- MCD胎儿的胼胝体生物测量参数减小,基于超声测量的CCL/ICOFD比值被认为是产前检测皮质畸形的 promising 工具。
研究设计与样本
- 单中心回顾性研究,纳入2017年4月至2022年8月孕20-37周的单胎胎儿,获取胎儿大脑正中矢状切面,测量胼胝体长度、高度、面积及相关标志物,计算CCL/ICOFD、CCL/FL和CCL/VD比值,采用组内相关系数(ICC)评估测量一致性,采用受试者工作特征曲线下面积(AUC)评估预测MCD的准确性。
关键影像表现/征象
- MCD胎儿胼胝体长度、膝部和压部高度及面积均显著低于正常胎儿(P<.05)。
- MCD胎儿与正常胎儿的身高无显著差异(P=.326)。
- MCD胎儿CCL/ICOFD、CCL/FL和CCL/VD比值均显著低于对照组(P<.05)。
诊断标准与关键数值
- CCL/ICOFD比值预测MCD的AUC为0.856(95%CI:0.774-0.938,P<.001)。
- CCL/FL比值预测MCD的AUC为0.780(95%CI:0.657-0.904,P<.001)。
- CCL/VD比值预测MCD的AUC为0.677(95%CI:0.559-0.795,P<.01)。
临床应用与阅片要点
- 作者认为,基于超声测量的CCL/ICOFD比值是产前检测皮质畸形的 promising 工具。
局限性
- 作者指出,需要对这些发现进行外部验证和前瞻性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate corpus callosum (CC) size in fetuses with malformations of cortical development (MCD) and to explore the diagnostic value of three CC length (CCL) ratios in identifying cortical abnormalities.
METHODS: This is a single-center retrospective study in singleton fetuses at 20-37 weeks of gestation between April 2017 and August 2022. The midsagittal plane of the fetal brain was obtained and evaluated for the following variables: length, height, area of the corpus callosum, and relevant markers, including the ratios of corpus callosum length to internal cranial occipitofrontal dimension (CCL/ICOFD), corpus callosum length to femur length (CCL/FL), and corpus callosum length to cerebellar vermian diameter (CCL/VD). Intra-class correlation coefficient (ICC) was used to evaluate measurement consistency. The accuracy of biometric measurements in prediction of MCD was assessed using the area under the receiver-operating-characteristics curves (AUC).
RESULTS: Fetuses with MCD had a significantly decreased CCL, height (genu and splenium), and area as compared with those of normal fetuses (P < .05), but there was no significant difference in body height (P = .326). The CCL/ICOFD, CCL/FL, and CCL/VD ratios were significantly decreased in fetuses with MCD when compared with controls (P < .05). The CCL/ICOFD ratio offered the highest predictive accuracy for MCD, yielding an AUC of 0.856 (95% CI: 0.774-0.938, P < .001), followed by CCL/FL ratio (AUC, 0.780 (95% CI: 0.657-0.904), P < .001), CCL/VD ratio (AUC, 0.677 (95% CI: 0.559-0.795), P < .01).
CONCLUSION: The corpus callosum biometric parameters in fetuses with MCD are reduced. The CCL/ICOFD ratio derived from sonographic measurements is considered a promising tool for the prenatal detection of cortical malformations. External validation of these findings and prospective studies are warranted.
引用
- Jiang YT, Zeng XJ, He M, et al. Disproportion of Corpus Callosum in Fetuses With Malformations of Cortical Development. J Ultrasound Med. 2024. PMID: 38558301. doi:10.1002/jum.16451
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。